Sorry, you need to enable JavaScript to visit this website.

Greenstone LLC Introduces OLANZAPINE Tablets
Generic of ZYPREXA®

PEAPACK, N.J., May 2012 — Greenstone LLC, the U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Olanzapine Tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg tablets.

Greenstone's Olanzapine Tablets product is the generic of ZYPREXA® (olanzapine) Tablets. This new generic complements Greenstone's line of generic products, and is backed by a commitment to integrity, quality, and supply reliability. As a subsidiary of Pfizer, Greenstone operates under the same values and commitment to bring quality medicines to customers, payers, and the patients they serve.

See the Full Prescribing Information for Greenstone's Olanzapine Tablets at http://www.greenstonellc.com/product-list.aspx. For more information about Greenstone LLC and its products, visit http://greenstonellc.com. GEODON® is a registered trademark of Pfizer Inc.